Quoin Pharmaceuticals, Ltd. — SC 13G Filings
13 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Quoin Pharmaceuticals, Ltd. (QNRX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Quoin Pharmaceuticals, Ltd. has filed 13 SC 13G documents with the SEC since 2016. To view all SEC filings by Quoin Pharmaceuticals, Ltd., see the full filings list.
All
10-K
10-Q
144
20-F
20-F/A
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-4
F-4/A
F-6
FWP
POS AM
POS EX
PRE 14A
RW
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0000929638-23-000798 | Mar 3, 2023 | — |
| SC 13G | SC 13G | 0001104659-22-089784 | Aug 12, 2022 | — |
| SC 13G | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-21-010999 | Nov 12, 2021 | — |
| SC 13G | CELLECT BIOTECHNOLOGY LTD. | 0000902664-21-000169 | Jan 13, 2021 | — |
| SC 13G | SC 13G | 0001104659-20-004930 | Jan 17, 2020 | — |
| SC 13G | CELLECT BIOTECHNOLOGY LTD. | 0000902664-20-000160 | Jan 10, 2020 | — |
| SC 13G | SC 13G | 0001193125-19-044389 | Feb 19, 2019 | — |
| SC 13G | SABBY 13G APOP 2.12.19 | 0001535610-19-000068 | Feb 12, 2019 | — |
| SC 13G | SABBY 13G APOP 02.01.18 | 0001535610-18-000056 | Feb 1, 2018 | — |
| SC 13G | SCHEDULE 13G | 0001144204-17-025622 | May 9, 2017 | — |
| SC 13G | SC 13G | 0001144204-17-012584 | Mar 3, 2017 | — |
| SC 13G | SC 13G | 0001144204-17-012581 | Mar 3, 2017 | — |
| SC 13G | SC 13G | 0001144204-17-008892 | Feb 14, 2017 | — |